EDUCATION FOR THE REFERRING EYE CARE SPECIALIST
Diagnosis and Treatment of Myopic Choroidal Neovascularization: Earlier Is Better
 
Release Date: April 28, 2017
Last Reviewed: March 14, 2017
Expiration Date: April 28, 2018
Time to Complete Activity: 1.0 hour

This activity is provided by Global Education Group.  Paradigm Medical Communications, LLC and Salus University Pennsylvania College of Optometry are the educational partners.              
                                                                                                                   
 
Faculty
Mark T. Dunbar, OD, FAAO (Co-Chair)
Director, Optometric Services
Optometric Residency Supervisor
University of Miami Bascom Palmer Eye Institute
Miami, FL
 
Sunir J. Garg, MD, FACS (Co-Chair)
Professor of Ophthalmology
The Retina Service of Wills Eye Hospital
Thomas Jefferson University
Partner, MidAtlantic Retina
Philadelphia, PA
 
Target Audience
This activity has been designed to address the educational needs of ophthalmologists and optometrists. It may also be of benefit to other healthcare providers interested in the management of myopic choroidal neovascularization (mCNV).
 
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Review the pathology and symptoms of myopic choroidal neovascularization as well as evidence-based diagnostic recommendations for detecting disease as early as possible.
  • Compare distinguishing features of anti-vascular endothelial growth factor agents commonly used to treat myopic choroidal neovascularization, including ease of administration, available formulations, and cost-effectiveness.
  • Evaluate recently reported data pertaining to the safety, efficacy, and treatment durability of anti-vascular endothelial growth factor agents for treating myopic choroidal neovascularization.
Table of Contents
Chapter 1 - Introduction
Chapter 2 - Diagnosing mCNV: Signs, Symptoms, and Tests
Chapter 3 - Anti-VEGF: A New Standard of Care for Patients with mCNV
Chapter 4 - Tying It All Together
Video Demonstration: New Ranibizumab Prefilled Syringe
Bibliography
Additional Resource
  • Optimizing SD-OCT: A Case Study
 
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.
 
Physician Credit Designation Statement
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Optometrist Continuing Education
COPE Accreditation Approved.
 
COPE ID#: 53246-PS
COPE Event #: 113395
 
Please consult your state’s Board of Optometry to determine if the CE credit may apply toward your CE requirement for license renewal.
 
This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate optometrist data to the Open Payments database.
 
Disclosure of Commercial Support
This activity is supported by an educational grant from Genentech, Inc.     
 
Instructions for Participation
To receive a CE certificate of participation, you must:
  • Follow instructions to register or log in with your professional information and complete the pre-course test.
  • View the online activity in its entirety.
  • Complete and submit the online post-course test and evaluation. You must answer 70% of the post-course test questions correctly to earn credit. You will have unlimited opportunities to successfully complete the post-course test.
     
A certificate of participation will be available for download/printing immediately following your successful completion of the post-course test and evaluation.
 
Please note: To claim COPE credit, please make sure you include your OE tracker number, address, state(s) of licensure and license number(s).
 
For questions regarding CE credit, contact the Paradigm CME Department at (845) 398-5949.

There is no fee required for participation in this activity.
 
Hardware/Software Requirements
This certified CE activity is designed using HTML5 video and audio.
 
Supported Browsers:
For desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
 
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
 
Technical Support: If you have any technical problems or playback issues, please email us at contactus@paradigmmc.com.
 
Disclosure and Resolution of Conflict of Interest
Global Education Group (Global), Paradigm Medical Communications, LLC (Paradigm), and Salus University Pennsylvania College of Optometry (Salus) require instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global, Paradigm, and Salus for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. 
 
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
 
Name of Faculty or Presenter
Reported Financial Relationship
Sunir J. Garg, MD, FACS (Chair)
Consultant/Independent Contractor: Santen Pharmaceutical Co., Ltd; Bausch & Lomb Incorporated; Deciphera Pharmaceuticals, LLC
Grant/Research Support: Allergan; EyeGate Pharma; Johnson & Johnson/Centocor, Inc.
Speakers Bureau: Allergan; Genentech, Inc.
Mark T. Dunbar, OD, FAAO
Honoraria (Advisory Board): Regeneron Pharmaceuticals, Inc; Genentech, Inc.
Speakers Bureau: Carl Zeiss AG
 
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
 
Name of Planner or Manager
Reported Financial Relationship
Lindsay Brovansky
No financial relationships to disclose
Laura Gilsdorf
No financial relationships to disclose
 
Salus University Pennsylvania College of Optometry is the post-course test sponsor, responsible for ensuring that the test administration and grading processes are objective and unbiased.

Salus University Pennsylvania College of Optometry staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.
 
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
 
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global, Paradigm, and Salus do not recommend the use of any agent outside of the labeled indications. 
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
 
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Global, Paradigm, or Salus. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Global, Paradigm, or Salus. Global, Paradigm, and Salus accept no liability for the content referenced in this activity.
 
Privacy policy
Global, Paradigm, and Salus are committed to protecting the privacy of those who participate in the activities (herein referred to as "website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
 
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CE activity. All evaluative information submitted is collected and retained, and used by Global, Paradigm, and Salus to continuously improve the learning experience.
 
Global, Paradigm, and Salus do not transfer, sell, or share personal information with outside parties. Global, Paradigm, and Salus will not otherwise disclose personal information unless required to in a legal process. Global, Paradigm and Salus staff members review individual test results to the extent necessary to record and track participants’ credits.
 
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
 
© 2017 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.